Tirzepatide vs Semaglutide
Side-by-side comparison of peptide medications.
| Feature | Tirzepatide | Semaglutide |
|---|---|---|
| Category | weight-loss | weight-loss |
| Administration | Subcutaneous injection (weekly) | Subcutaneous injection (weekly) |
| Prescription Required | Yes | Yes |
Tirzepatide
A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semaglutide results.
Common uses: Weight loss, Type 2 diabetes management, Metabolic health
Semaglutide
A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely prescribed for weight management. Reduces appetite and slows gastric emptying.
Common uses: Weight loss, Blood sugar regulation, Appetite suppression